Did you know DNA repairs itself?

DNA repair is a central guardian of genome stability. Every cell constantly faces DNA damage from ultraviolet radiation, ionizing radiation, reactive oxygen species, replication errors, alkylating agents, hydrolytic deamination, and endogenous metabolic stress. Without efficient repair, these lesions can block replication, alter transcription, create mutations, promote chromosomal instability, and drive cancer, aging, neurodegeneration, immune dysfunction, and developmental failure.

Base excision repair corrects small chemical base lesions. This pathway removes subtle damage such as oxidized bases, deaminated bases, and alkylated bases. DNA glycosylases first recognize abnormal bases and cleave the N glycosidic bond, producing an abasic site. AP endonuclease then cuts the DNA backbone, DNA polymerase fills the gap, and DNA ligase seals the strand. This pathway is crucial for repairing oxidative lesions such as 8 oxoguanine, which can otherwise mispair with adenine and create G to T mutations.

AI Generated depiction @FST (may not be accurately demonstrated)

Nucleotide excision repair removes bulky helix distorting lesions. This mechanism repairs ultraviolet induced cyclobutane pyrimidine dimers, 6 4 photoproducts, and bulky chemical adducts. Damage recognition is followed by local DNA unwinding, dual incision around the lesion, removal of a short damaged oligonucleotide, gap filling by DNA polymerase, and ligation. Defects in this pathway cause xeroderma pigmentosum, a disorder marked by extreme sunlight sensitivity and high skin cancer risk.

Mismatch repair maintains replication fidelity. During DNA replication, incorrect base pairing and small insertion or deletion loops can escape polymerase proofreading. Mismatch repair proteins identify the newly synthesized strand, remove the error containing segment, and resynthesize the correct sequence. Loss of mismatch repair causes microsatellite instability and is strongly associated with Lynch syndrome and several colorectal, endometrial, and gastric cancers.

Homologous recombination repairs dangerous double strand breaks accurately. This pathway uses an undamaged sister chromatid as a template, making it highly faithful. It involves end resection, RAD51 mediated strand invasion, DNA synthesis, branch migration, and resolution. BRCA1 and BRCA2 are central regulators of this process. Defects in homologous recombination increase genomic instability and sensitize tumors to PARP inhibitors through synthetic lethality.

Non homologous end joining repairs double strand breaks rapidly but less precisely. Ku70 and Ku80 bind broken DNA ends, recruit DNA PKcs, process damaged termini, and ligate ends through XRCC4, XLF, and ligase IV. This pathway is active throughout the cell cycle and is essential in immune receptor diversification, especially during V(D)J recombination. However, it can introduce small insertions or deletions.

Translesion synthesis allows replication across damaged DNA. Specialized polymerases bypass lesions that would otherwise stall replication forks. These polymerases have flexible active sites but lower fidelity, making the pathway protective in the short term yet mutagenic if overused.

DNA damage response signaling coordinates repair with cell fate. ATM, ATR, DNA PK, CHK1, CHK2, p53, gamma H2AX, PARP1, and ubiquitin signaling networks detect lesions, pause the cell cycle, recruit repair complexes, remodel chromatin, and determine whether the cell repairs, senesces, or undergoes apoptosis.

At the highest biological level, DNA repair is not merely damage correction. It is an integrated decision system balancing survival, mutation tolerance, replication continuity, epigenomic organization, cancer suppression, immune diversity, and evolutionary adaptability.